DR. MATTHEW E RUTTER M.D. NPI 1588650758

NPI Details

DR. Matthew E Rutter, M.D. is an urology in Bowling Green, KY with 29 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Matthew E Rutter, M.D. NPI is 1588650758. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL COLLEGE OF OHIO
Graduation Year:1997

The provider's business location address is:

201 PARK ST
BOWLING GREEN, KY
ZIP 42101-759
Phone: (270) 781-5111
Fax: (270) 780-0498

The NPI 1588650758 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Automated urinalysis test (HCPCS:81003)
• Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Bacterial colony count, urine (HCPCS:87086)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Bacterial urine culture (HCPCS:87088)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Blood creatinine level (HCPCS:82565)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Biopsy of prostate gland (HCPCS:55700)
• X-ray of chest, 2 views (HCPCS:71046)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Testosterone (hormone) level, total (HCPCS:84403)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• 3d radiographic procedure with computerized image postprocessing (HCPCS:76377)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm (HCPCS:52234)
• Ct scan of abdomen before and after contrast (HCPCS:74170)
• Mri scan of pelvis before and after contrast (HCPCS:72197)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Exam with injections of chemical for destruction of bladder using an endoscope (HCPCS:52287)
• Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
• Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9503)
• Removal of kidney and lymph nodes using an endoscope (HCPCS:50545)
• Surgical removal of prostate and surrounding lymph nodes using an endoscope (HCPCS:55866)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Blood test, clotting time (HCPCS:85610)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 9/23/2005 and was last updated on 7/2/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.